EPO has been shown to directly modulate Kupffer cell activity, the liver-resident macrophage population (Gilboa et al., 2017), and preliminary clinical data suggested that EPO, in combination with granulocyte colony-stimulating factor, may improve outcomes in patients with decompensated cirrhosis (Kedarisetty et al., 2015). Here, EPO is linked to Cirrhosis.